News

Eli Lilly and Company (LLY): We Sold Some Lilly, Says Jim Cramer
We recently published 12 Stocks Jim Cramer Recently Discussed As He Commented On A “Sea Of Green”. Eli Lilly and Company ...
Eli Lilly Weight-Loss Drug Makes Cardio Advance. More Bad News for Novo Nordisk.
A Lilly study showed Mounjaro resulted in a lower risk of heart attacks and strokes in patients with diabetes compared with ...
Eli Lilly’s stock drops as Trump targets 17 drug makers with letters on their pricing
Shares of Eli Lilly & Co. erased gains to trade down nearly 1% after White House press secretary Karoline Leavitt said the company was among 17 drugmakers that will be receiving letters from President ...
Eli Lilly and Biogen/Eisai’s extension trials make waves in Alzheimer’s market
Lilly’s Kisunla and Biogen/Eisai’s Leqembi can both continue to slow Alzheimer's cognitive decline after more than three ...
Eli Lilly’s Jaypirca succeeds in late-stage trial against Imbruvica of J&J and AbbVie
Eli Lilly (LLY) stock in focus as its cancer drug Jaypirca hits main goal in a Phase 3 trial against Imbruvica of J&J (JNJ) ...
What's Going On With Eli Lilly Stock On Tuesday?
Eli Lilly stock slips after Novo Nordisk trims 2025 forecast; Jaypirca meets endpoint in CLL trial against J&J's Imbruvica, ...
Clinical Trials Arena on MSN1d
Eli Lilly eyes SoC status as Jaypirca proves superior to Imbruvica in CLL/SLL
Eli Lilly’s Jaypirca (pirtobrutinib) has been shown to be superior to Johnson & Johnson (J&J) and AbbVie’s star Bruton's ...
PharmExec3d
Eli Lilly and Company Acquires Vere Therapeutics to Further Develop One-Time Cardiovascular Treatments
Eli Lilly's acquisition of Vere Therapeutics promises to revolutionize cardiovascular care with innovative one-time gene ...